Synthesis and pharmacology of 2-alkyl raloxifene analogs

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 2, 1996, Pages 201-206

  Grese, Timothy A ^a   Cho, Stephen ^a   Bryant, Henry U ^a   Cole, Harlan W ^a   Glasebrook, Andrew L ^a   Magee, David E ^a   Phillips, D Lynn ^a   Rowley, Ellen R ^a   Short, Lorri L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 HYDROXYCYCLOHEXYL)RALOXIFENE; CHOLESTEROL; ESTRADIOL; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; RALOXIFENE; RALOXIFENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LIPID METABOLISM; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; UTERUS WEIGHT;

EID: 0030025887     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(95)00575-E     Document Type: Article

References (18)

1. Lindsay, R. In Osteoporosis: Etiology, Diagnosis, and Management; Riggs, B. L.; Melton, L. J., Eds.; Raven: New York, 1988; p 333.
2. Ross, R. K.; Pike, M. C.; Mack, T. M.; Henderson, B. E. In HRT and Osteoporosis; Drife, J. O.; Studd, J. W. W., Eds.; Springer-Verlag: London, 1990; p 209.
3. Cust, M. P.; Gangar, K. F.; Whitehead, M. I. In HRT and Osteoporosis; Drife, J. O.; Studd, J. W. W., Eds.; Springer-Verlag: London, 1990; p 177.
4. Session, D. R.; Kelly, A. C.; Jewelewicz, R. Fertility and Sterility 1993, 2, 277; and references therein.
5. Colditz, G. A.; Hankinson, S. E.; Hunter, D. J.; Willett, W. C.; Manson, J. E.; Stampfer, M. J.; Hennekens, C.; Rosner, B.; Speizer, F. E. New Eng. J. Med. 1995, 332, 1589.
6. Black, L. J.; Sato, M.; Rowley, E. R.; Magee, D. E.; Bekele, A.; Williams, D. C.; Cullinan, G. J.; Bendele, R.; Kauffman, R. F.; Bensch, W. R.; Frolik, C. A.; Termine, J. D.; Bryant, H. U. J. Clin. Invest. 1994, 93, 63.
7. Ke, H. Z.; Simmons, H. A.; Pirie, C. M.; Crawford, T.; Thompson, D. D. Endocrinology 1995, 136, 2435.
8. Grese, T. A.; Bryant, H. U.; Cole, H. W.; Kim, J. R.; Magee, D. E.; Rowley, E. R.; Sato, M. J. Bone Miner. Res. 1995, 10 (Suppl 1), S458.
9. Termine, J. D. Presented at American Society of Bone and Mineral Research, 16th Annual Meeting, Kansas City, MO, 1994, Minisymposia A: Estrogens and Anti-Estrogens.
10. Draper, M. W.; Flowers, D. E.; Huster, W. J.; Neild, J. A. Proceedings of the Fourth International Symposium on Osteoporosis 1993, 119.
11. During the course of this study a patent abstract describing the preparation of some of these compounds by an alternative method appeared. Koizumi, N.; Takegawa, S.; Iwashita, S.; Saito, T.; Kawachi, T.; Matsui, T. WO 9310113, 1993.
12. Godfrey, A. G., US 5,420,349.
13. Cullinan, G. J.; Jones, C. D., unpublished results.
14. Ricci, A.; Taddei, M. J. Organomet. Chem. 1986, 306, 23.
15. Glasebrook, A. L.; Phillips, D. L.; Sluka, J. P. J. Bone Miner. Res. 1993, 8 (Suppl 1), S268.
16. Thompson, E. W.; Reich, R.; Shima, T. B.; Albini, A.; Graf, J.; Martin, G. R.; Dickson, R. B.; Lippman, M. E. Cancer Res. 1988, 48, 6764.
17. Bryant, H. U.; Bendele, A. M.; Magee, D. E.; Cole, H. W.; Spaethe, S. W. Pharmacologist 1992, 34, 194.
18. All new compounds exhibited appropriate 1H-NMR, 13C-NMR, IR, MS and/or elemental analysis.